Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Women's Health Diagnostics was valued at USD 31.3 Billion in 2024 and is projected to reach USD 43.9 Billion by 2030, growing at a CAGR of 5.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers and forecasts.
Technological advancements in molecular diagnostics, imaging, and point-of-care testing are significantly transforming women's health diagnostics. The development of next-generation sequencing (NGS), liquid biopsy, and companion diagnostics is enabling more precise and non-invasive detection of genetic mutations, cancers, and other health conditions, leading to better-targeted therapies and personalized treatment plans. Innovations in imaging technologies, such as 3D mammography, ultrasound, and magnetic resonance imaging (MRI), are providing more accurate and detailed visualization of breast tissues, enhancing early detection and diagnosis of breast cancer. Additionally, the integration of AI-driven analytics, digital pathology, and telemedicine is improving the accessibility, efficiency, and accuracy of women's health diagnostics, making them more patient-friendly and cost-effective.
What Are the Challenges and Opportunities in the Women's Health Diagnostics Market?
The women's health diagnostics market faces several challenges, including the high cost of advanced diagnostic tests, limited access to quality healthcare in low-income regions, and the need for increased awareness and education about women's health issues. The regulatory and reimbursement landscape for diagnostic tests can also be complex and time-consuming. However, these challenges present significant opportunities for growth and innovation. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and osteoporosis, is driving the demand for early detection and preventive diagnostics. The rise of personalized medicine, telehealth, and home-based testing is creating new growth opportunities for diagnostic manufacturers to offer innovative, accessible, and affordable solutions. Moreover, the growing focus on women's health advocacy, government initiatives, and public health campaigns is driving the need for comprehensive and integrated women's health diagnostics.
What Is Driving the Growth of the Women's Health Diagnostics Market?
The growth in the Women's Health Diagnostics market is driven by several factors, including the increasing prevalence of chronic and lifestyle-related diseases among women, rising demand for early detection and personalized medicine, and technological advancements in molecular diagnostics, imaging, and AI-driven analytics. The need for comprehensive and accurate diagnostic solutions that offer early detection, non-invasive testing, and targeted therapies is significantly boosting market demand as healthcare providers and patients seek to improve health outcomes and quality of life for women. Technological innovations such as next-generation sequencing, digital pathology, AI-driven diagnostics, and telemedicine are enhancing the capabilities and accessibility of women's health diagnostics, making them more attractive to both healthcare professionals and patients. The expansion of preventive care, the growth of telehealth and home-based testing, and the increasing focus on women's health advocacy and awareness are also driving market growth as stakeholders seek advanced and integrated diagnostic solutions for women's health.
Report Scope
The report analyzes the Women's Health Diagnostics market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments
- Application (Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing, Other Applications)
- End-Use (Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care)
Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Breast Cancer Testing segment, which is expected to reach $11.3 Billion by 2030 with a CAGR of a 7.4%. The Infectious Disease Testing segment is also set to grow at 4.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $8.2 Billion in 2024, and China, forecasted to grow at an impressive 9.9% CAGR to reach $10.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Alere, Inc., GE Healthcare, Hologic, Inc., Koninklijke Philips NV, Quest Diagnostics, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Women's Health Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 41 major companies featured in this Women's Health Diagnostics market report include:
- Alere
- GE Healthcare
- Hologic
- Koninklijke Philips
- Quest Diagnostics
- Siemens
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 173 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $31.3 Billion |
| Forecasted Market Value (USD) by 2030 | $43.9 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Women's Health Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Rising Prevalence of Chronic Diseases and Growing Awareness for Early Detection in Women
- Increasing Demand for Point-of-Care and Home-Based Diagnostic Solutions
- Advancements in Molecular Diagnostics and Next-Generation Sequencing for Women's Health
- Growing Focus on Personalized Medicine and Companion Diagnostics for Targeted Therapies
- Impact of Digital Health and Telemedicine on Women's Health Diagnostics Accessibility
FOCUS ON SELECT PLAYERS
- Alere, Inc.
- GE Healthcare
- Hologic, Inc.
- Koninklijke Philips NV
- Quest Diagnostics, Inc.
- Siemens AG
For more information about this report visit https://www.researchandmarkets.com/r/my4mpr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
